34940029|t|Potential Combination Drug Therapy to Prevent Redox Stress and Mitophagy Dysregulation in Retinal Muller Cells under High Glucose Conditions: Implications for Diabetic Retinopathy.
34940029|a|Chronic hyperglycemia-induced thioredoxin-interacting protein (TXNIP) expression, associated oxidative/nitrosative stress (ROS/RNS), and mitochondrial dysfunction play critical roles in the etiology of diabetic retinopathy (DR). However, there is no effective drug treatment to prevent or slow down the progression of DR. The purpose of this study is to examine if a combination drug treatment targeting TXNIP and the mitochondria-lysosome pathway prevents high glucose-induced mitochondrial stress and mitophagic flux in retinal Muller glial cells in culture, relevant to DR. We show that diabetes induces TXNIP expression, redox stress, and Muller glia activation (gliosis) in rat retinas when compared to non-diabetic rat retinas. Furthermore, high glucose (HG, 25 mM versus low glucose, LG 5.5 mM) also induces TXNIP expression and mitochondrial stress in a rat retinal Muller cell line, rMC1, in in vitro cultures. Additionally, we develop a mitochondria-targeted mCherry and EGFP probe tagged with two tandem COX8a mitochondrial target sequences (adenovirus-CMV-2xmt8a-CG) to examine mitophagic flux in rMC1. A triple drug combination treatment was applied using TXNIP-IN1 (which inhibits TXNIP interaction with thioredoxin), Mito-Tempo (mitochondrial anti-oxidant), and ML-SA1 (lysosome targeted activator of transient calcium channel MCOLN1/TRPML1 and of transcription factor TFEB) to study the mitochondrial-lysosomal axis dysregulation. We found that HG induces TXNIP expression, redox stress, and mitophagic flux in rMC1 versus LG. Treatment with the triple drug combination prevents mitophagic flux and restores transcription factor TFEB and PGC1alpha nuclear localization under HG, which is critical for lysosome biosynthesis and mitogenesis, respectively. Our results demonstrate that 2xmt8a-CG is a suitable probe for monitoring mitophagic flux, both in live and fixed cells in in vitro experiments, which may also be applicable to in vivo animal studies, and that the triple drug combination treatment has the potential for preventing retinal injury and disease progression in diabetes.
34940029	122	129	Glucose	Chemical	MESH:D005947
34940029	159	179	Diabetic Retinopathy	Disease	MESH:D003930
34940029	181	202	Chronic hyperglycemia	Disease	MESH:D006943
34940029	211	242	thioredoxin-interacting protein	Gene	117514
34940029	244	249	TXNIP	Gene	117514
34940029	304	307	ROS	Chemical	-
34940029	308	311	RNS	Chemical	MESH:D011886
34940029	318	343	mitochondrial dysfunction	Disease	MESH:D028361
34940029	383	403	diabetic retinopathy	Disease	MESH:D003930
34940029	405	407	DR	Disease	MESH:D003930
34940029	499	501	DR	Disease	MESH:D003930
34940029	585	590	TXNIP	Gene	117514
34940029	643	650	glucose	Chemical	MESH:D005947
34940029	659	672	mitochondrial	Disease	MESH:D028361
34940029	754	756	DR	Disease	MESH:D003930
34940029	771	779	diabetes	Disease	MESH:D003920
34940029	788	793	TXNIP	Gene	117514
34940029	848	855	gliosis	Disease	MESH:D005911
34940029	860	863	rat	Species	10116
34940029	893	901	diabetic	Disease	MESH:D003920
34940029	902	905	rat	Species	10116
34940029	933	940	glucose	Chemical	MESH:D005947
34940029	963	970	glucose	Chemical	MESH:D005947
34940029	996	1001	TXNIP	Gene	117514
34940029	1017	1030	mitochondrial	Disease	MESH:D028361
34940029	1043	1046	rat	Species	10116
34940029	1073	1077	rMC1	CellLine	CVCL:8140
34940029	1196	1201	COX8a	Gene	171335
34940029	1202	1215	mitochondrial	Disease	MESH:D028361
34940029	1234	1248	adenovirus-CMV	Species	
34940029	1290	1294	rMC1	CellLine	CVCL:8140
34940029	1350	1355	TXNIP	Gene	117514
34940029	1376	1381	TXNIP	Gene	117514
34940029	1399	1410	thioredoxin	Gene	116484
34940029	1413	1423	Mito-Tempo	Chemical	MESH:C555916
34940029	1425	1438	mitochondrial	Disease	MESH:D028361
34940029	1458	1464	ML-SA1	Chemical	-
34940029	1523	1529	MCOLN1	Gene	288371
34940029	1565	1569	TFEB	Gene	316214
34940029	1584	1597	mitochondrial	Disease	MESH:D028361
34940029	1653	1658	TXNIP	Gene	117514
34940029	1708	1712	rMC1	CellLine	CVCL:8140
34940029	1826	1830	TFEB	Gene	316214
34940029	1835	1844	PGC1alpha	Gene	83516
34940029	2232	2246	retinal injury	Disease	MESH:D012173
34940029	2274	2282	diabetes	Disease	MESH:D003920
34940029	Bind	116484	117514
34940029	Association	MESH:D003930	117514
34940029	Association	MESH:D028361	117514
34940029	Association	MESH:D028361	171335
34940029	Negative_Correlation	MESH:C555916	117514
34940029	Positive_Correlation	MESH:D006943	117514
34940029	Negative_Correlation	MESH:C555916	MESH:D028361
34940029	Positive_Correlation	MESH:D005947	MESH:D028361
34940029	Positive_Correlation	MESH:D005947	117514
34940029	Positive_Correlation	MESH:D003920	117514
34940029	Negative_Correlation	117514	83516

